Literature DB >> 10986217

TNF-alpha dependent production of inducible nitric oxide is involved in PGE(1) protection against acute liver injury.

J Muntané1, F J Rodríguez, O Segado, A Quintero, J M Lozano, E Siendones, C A Pedraza, M Delgado, F O'Valle, R García, J L Montero, M De La Mata, G Miño.   

Abstract

BACKGROUND: Tumour necrosis factor alpha (TNF-alpha) and nitric oxide modulate damage in several experimental models of liver injury. We have previously shown that protection against D-galactosamine (D-GalN) induced liver injury by prostaglandin E(1) (PGE(1)) was accompanied by an increase in TNF-alpha and nitrite/nitrate in serum. AIMS: The aim of the present study was to evaluate the role of TNF-alpha and nitric oxide during protection by PGE(1) of liver damage induced by D-GalN.
METHODS: Liver injury was induced in male Wistar rats by intraperitoneal injection of 1 g/kg of D-GalN. PGE(1) was administered 30 minutes before D-GalN. Inducible nitric oxide synthase (iNOS) was inhibited by methylisothiourea (MT), and TNF-alpha concentration in serum was lowered by administration of anti-TNF-alpha antibodies. Liver injury was evaluated by alanine aminotransferase activity in serum, and histological examination and DNA fragmentation in liver. TNF-alpha and nitrite/nitrate concentrations were determined in serum. Expression of TNF-alpha and iNOS was also assessed in liver sections.
RESULTS: PGE(1) decreased liver injury and increased TNF-alpha and nitrite/nitrate concentrations in serum of rats treated with D-GalN. PGE(1) protection was related to enhanced expression of TNF-alpha and iNOS in hepatocytes. Administration of anti-TNF-alpha antibodies or MT blocked the protection by PGE(1) of liver injury induced by D-GalN.
CONCLUSIONS: This study suggests that prior administration of PGE(1) to D-GalN treated animals enhanced expression of TNF-alpha and iNOS in hepatocytes, and that this was causally related to protection by PGE(1) against D-GalN induced liver injury.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10986217      PMCID: PMC1728088          DOI: 10.1136/gut.47.4.553

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  66 in total

Review 1.  Inflammation, immunoregulation, and inducible nitric oxide synthase.

Authors:  A K Nussler; T R Billiar
Journal:  J Leukoc Biol       Date:  1993-08       Impact factor: 4.962

Review 2.  Galactosamine induced liver injury.

Authors:  K Decker; D Keppler
Journal:  Prog Liver Dis       Date:  1972

3.  Cytoprotective effects of nitric oxide.

Authors:  J P Cooke; P S Tsao
Journal:  Circulation       Date:  1993-11       Impact factor: 29.690

4.  TNF-alpha but not IL-1alpha is correlated with PGE1-dependent protection against acute D-galactosamine-induced liver injury.

Authors:  J Muntané; J L Montero; J M Lozano; A Miranda-Vizuete; M de La Mata; G Miño
Journal:  Can J Gastroenterol       Date:  2000-03       Impact factor: 3.522

5.  Hepatic injury and lethal shock in galactosamine-sensitized mice induced by the superantigen staphylococcal enterotoxin B.

Authors:  M Nagaki; Y Muto; H Ohnishi; S Yasuda; K Sano; T Naito; T Maeda; T Yamada; H Moriwaki
Journal:  Gastroenterology       Date:  1994-02       Impact factor: 22.682

6.  Prostaglandin E2 inhibits the release of tumor necrosis factor-alpha, rather than interleukin 1 beta, from human macrophages.

Authors:  M W Fieren; G J van den Bemd; S Ben-Efraim; I L Bonta
Journal:  Immunol Lett       Date:  1992-01       Impact factor: 3.685

7.  Hepatic and gastric cytoprotective effects of long-term prostaglandin E1 administration in cirrhotic rats.

Authors:  P L Beck; G W McKnight; J K Kelly; J L Wallace; S S Lee
Journal:  Gastroenterology       Date:  1993-11       Impact factor: 22.682

8.  Modulation of thioacetamide-induced hepatocellular necrosis by prostaglandins is associated with novel histologic changes.

Authors:  N V Bergasa; M J Borque; L M Wahl; L Rabin; E A Jones
Journal:  Liver       Date:  1992-08

9.  Nitric oxide production in experimental alcoholic liver disease in the rat: role in protection from injury.

Authors:  A A Nanji; S S Greenberg; S R Tahan; F Fogt; J Loscalzo; S M Sadrzadeh; J Xie; J S Stamler
Journal:  Gastroenterology       Date:  1995-09       Impact factor: 22.682

10.  Hepatocyte-derived interleukin-6 and tumor-necrosis factor alpha mediate the lipopolysaccharide-induced acute-phase response and nitric oxide release by cultured rat hepatocytes.

Authors:  B Saad; K Frei; F A Scholl; A Fontana; P Maier
Journal:  Eur J Biochem       Date:  1995-04-15
View more
  11 in total

1.  Inducible nitric oxide has protective effect on fumonisin B1 hepatotoxicity in mice via modulation of sphingosine kinase.

Authors:  Hirofumi Suzuki; Ronald T Riley; Raghubir P Sharma
Journal:  Toxicology       Date:  2006-09-29       Impact factor: 4.221

2.  Effect of leflunomide on immunological liver injury in mice.

Authors:  Hong-Wei Yao; Jun Li; Yong Jin; Yun-Fang Zhang; Chang-Yu Li; Shu-Yun Xu
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

3.  FR167653 attenuates murine immunological liver injury.

Authors:  Hong-Wei Yao; Jun Li; Ji-Qiang Chen
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

4.  Tumor necrosis factor-alpha-induced reduction of glomerular filtration rate in rats with fulminant hepatic failure.

Authors:  Jing-Bo Wang; Dong-Lei Wang; Hai-Tao Wang; Zhao-Han Wang; Ying Wen; Cui-Ming Sun; Yi-Tong Zhao; Jian Wu; Pei Liu
Journal:  Lab Invest       Date:  2014-06-02       Impact factor: 5.662

5.  Protective role of puerarin on LPS/D-Gal induced acute liver injury via restoring autophagy.

Authors:  Long Li; Hongyan Yin; Yan Zhao; Xiaofang Zhang; Chaoli Duan; Jing Liu; Caoxin Huang; Suhuan Liu; Shuyu Yang; Xuejun Li
Journal:  Am J Transl Res       Date:  2018-03-15       Impact factor: 4.060

6.  Exogenous adenosine 5'-triphosphate does not improve survival in rats with acute liver failure.

Authors:  Erin P Becker; DongFeng Sun; Gerald Y Minuk
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

Review 7.  Management of drug-induced liver disease.

Authors:  G Marino; H J Zimmerman; J H Lewis
Journal:  Curr Gastroenterol Rep       Date:  2001-02

8.  Anti-inflammatory, antioxidant and antihepatotoxic effects of Spirulina platensis against d-galactosamine induced hepatotoxicity in rats.

Authors:  Wahidah H Al-Qahtani; Manal Abdulaziz Binobead
Journal:  Saudi J Biol Sci       Date:  2018-02-06       Impact factor: 4.219

9.  Premobilization of CD133+ cells by granulocyte colony- stimulating factor attenuates ischemic acute kidney injury induced by cardiopulmonary bypass.

Authors:  Xiaoqiang Li; Qin Wan; Jie Min; Linjia Duan; Jin Liu
Journal:  Sci Rep       Date:  2019-02-21       Impact factor: 4.379

10.  Probiotic Lactobacillus casei Shirota prevents acute liver injury by reshaping the gut microbiota to alleviate excessive inflammation and metabolic disorders.

Authors:  Ren Yan; Kaicen Wang; Qiangqiang Wang; Huiyong Jiang; Yingfeng Lu; Xiaoxiao Chen; Hua Zhang; Xiaoling Su; Yiling Du; Lifeng Chen; Lanjuan Li; Longxian Lv
Journal:  Microb Biotechnol       Date:  2021-01-25       Impact factor: 5.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.